Life Infusion Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.80 Cr
as on 03-07-2024
- Paid Up Capital ₹ 6.74 Cr
as on 03-07-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.00 Cr
as on 03-07-2024
About Life Infusion Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.80 Cr and a paid-up capital of Rs 6.74 Cr.
The company currently has active open charges totaling ₹26.00 Cr.
Shakkeer Hussain, Unais Cherumala, Abbas Kuvappara, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999KL2019PTC060262
- Company No.
060262
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Life Infusion Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Unais Cherumala  | Managing Director | 07-Nov-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abbas Kuvappara | Director | 02-Feb-2021 | Current |
| Shakkeer Hussain | Director | 07-Nov-2019 | Current |
| Saheed Kottoth | Director | 23-Sep-2020 | Current |
Financial Performance of Life Infusion Pharmaceuticals.
Life Infusion Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Life Infusion Pharmaceuticals?
Unlock access to Life Infusion Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Spandex Techno Fab Private LimitedActive 11 years 8 monthsShakkeer Hussain, Unais Cherumala and 1 more are mutual person
- Rappo Foods Private LimitedActive 7 years 28 days
Shakkeer Hussain and Saheed Kottoth are mutual person
- United Pravasi Builders And Developers L LpActive 8 years 9 months
Shakkeer Hussain is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 May 2022 | ₹26.00 Cr | Open |
How Many Employees Work at Life Infusion Pharmaceuticals?
Unlock and access historical data on people associated with Life Infusion Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Life Infusion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Life Infusion Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
